Search for: "Allergan Sales LLC"
Results 21 - 40
of 44
Sorted by Relevance
|
Sort by Date
11 May 2020, 3:59 am
McGraw-Hill is owned by Apollo Global Management LLC (APO.N). [read post]
21 Jul 2021, 12:44 pm
The manufacturers named in the complaint included Purdue Pharma and its affiliates, as well as members of the Sackler Family (owners of Purdue) and trusts they control; Janssen Pharmaceuticals and its affiliates (including its parent company Johnson & Johnson); Mallinckrodt LLC and its affiliates; Endo Health Solutions and its affiliates; Teva Pharmaceuticals USA, Inc. and its affiliates; and Allergan Finance, LLC and its affiliates. [read post]
15 Dec 2023, 8:49 am
ImprimisRx, LLC v. [read post]
21 Sep 2018, 4:47 am
Allergan Sales, LLC v. [read post]
20 Jun 2017, 9:23 am
Allergan, Inc., et al., No. 16-3334, 7th Cir. (2017)). [read post]
17 Aug 2018, 5:58 am
Companies that invent in that area include: Abbot Allergan AMO Development, LLC Applied Medical Resources Corp. [read post]
28 Sep 2017, 12:22 pm
Calamari’s tenure as Regional Director, the New York office has brought many significant enforcement actions, including charges against:National audit firm BDO USA for dismissing red flags and issuing false and misleading unqualified audit opinions about the financial statements of staffing services company General Employment Enterprises Pharmaceutical company Allergan Inc. for disclosure failures in the wake of a… [read post]
18 Dec 2011, 7:37 pm
Under Section 301(k) of the FDCA, misbranding also includes: “the alteration, mutilation, destruction, obliteration, or removal of the whole or any part of the labeling of, or the doing of any other act with respect to, a food, drug, device, or cosmetic, if such act is done while such article is held for sale (whether or not the first sale) after shipment in interstate commerce and results in such article being adulterated or misbranded. [read post]
28 Apr 2017, 8:59 am
Allergan, Inc. v. [read post]
6 Sep 2022, 3:28 pm
Allergan Sales, LLC affirmed dismissal of allegations that the defendant intentionally reported a higher “best price” to the government by failing to aggregate stacked discounts. [read post]
15 Jun 2023, 1:09 pm
Allergan Sales, LLC present variations on that issue arising under different factual circumstances. [read post]
6 Mar 2014, 12:41 pm
Because Bexis is updating chapter two (information-based claims) of his book, he has some ideas for some shorter lists of interesting cases. [read post]
27 Feb 2009, 5:00 am
(Patent Baristas) US: Teva releases second video in year of affordable healthcare campaign (SmartBrief) US: Discussion of NYT article ‘Crop Scientists Say Biotechnology Seed Companies are Thwarting Research’ (Patent Docs) (Patent Baristas) US FDA: Genetically engineered organisms can be patented (RelatIP) US: Kabushiki Kaisha Hayashibara Seibutsu Kaguku Kenkyujo seeks review and correction of patent term adjustment for patent covering ‘embolic materials’… [read post]
13 May 2010, 12:27 pm
Allergan USA, Inc., 2009 WL 3294873 (D. [read post]
15 Apr 2021, 11:48 am
Allergan, Philadelphia Court of Common Pleas, No. 180102718; City of San Francisco v. [read post]
10 Feb 2016, 12:42 pm
Compare Allergan, Inc. v. [read post]
11 Jul 2008, 4:30 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: ACTA continues to be discussed and debated: (Michael Geist), (Intellectual Property Watch), (Public Knowledge), (Techdirt), (Managing Intellectual Property), (Public Knowledge), (Public Knowledge), (Public Knowledge), Apotex challenge to Acular LS patent barred by res judicata: Roche Palo Alto & Allergan v Apotex:… [read post]
29 Jun 2023, 3:33 pm
ShareThe Relist Watch column examines cert petitions that the Supreme Court has “relisted” for its upcoming conference. [read post]
23 Jun 2023, 6:55 am
Share The Relist Watch column examines cert petitions that the Supreme Court has “relisted” for its upcoming conference. [read post]
31 Dec 2014, 5:00 am
It joins an “overwhelming” majority of appellate courts to reaffirm the “well-settled” rule that product liability lies only against those involved in the manufacture and sale of products. [read post]
